Neurogenic peptides and the cardiomyopathy of magnesium-deficiency: effects of substance P-receptor inhibition.
Weglicki WB, Mak IT, Stafford RE, Dickens BF, Cassidy MM, Phillips TM.
Weglicki WB, et al. Among authors: phillips tm.
Mol Cell Biochem. 1994 Jan 26;130(2):103-9. doi: 10.1007/BF01457391.
Mol Cell Biochem. 1994.
PMID: 8028589
Recently, we identified an early elevation of circulating substance P and proposed a role of neurogenic peptides during Mg-deficiency (Weglicki WB, Phillips TM: AM J Phys 1992;262:R734). The present study was designed to evaluate the contribution of neurogenic pepti …
Recently, we identified an early elevation of circulating substance P and proposed a role of neurogenic peptides during Mg-deficiency (Wegli …